Posted in | News | Business | Composites

Michelman Joins National Composites Center

Michelman has joined the National Composites Center (NCC), based in Kettering, Ohio, USA, to augment its fibers and composites development team with research, laboratory, testing and collaboration capabilities.

Michelman manufactures a variety of polymeric dispersions and emulsions used as fiber sizing and lubricants critical to the production of composite materials.

The NCC (www.compositecenter.org) is recognized as the national center of excellence for the development and commercialization of composite materials and manufacturing processes for the aerospace, defense, ground transportation, commercial and infrastructure markets. The Center helps its members develop innovative solutions, and shorten product development time through technology transfer and collaboration, engineering expertise, laboratory and pilot production capabilities.

According to Dr. Andy Brink, Global Technology and Business Development Manager for Fibers & Composites at Michelman, "Being part of the NCC will allow us to network with other members, and collaborate on innovative product development ideas and opportunities. Our combined resources will allow us to bring innovative solutions to the fibers and composites markets more quickly and cost effectively.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Michelman Inc. (2019, February 09). Michelman Joins National Composites Center. AZoM. Retrieved on November 23, 2024 from https://www.azom.com/news.aspx?newsID=33159.

  • MLA

    Michelman Inc. "Michelman Joins National Composites Center". AZoM. 23 November 2024. <https://www.azom.com/news.aspx?newsID=33159>.

  • Chicago

    Michelman Inc. "Michelman Joins National Composites Center". AZoM. https://www.azom.com/news.aspx?newsID=33159. (accessed November 23, 2024).

  • Harvard

    Michelman Inc. 2019. Michelman Joins National Composites Center. AZoM, viewed 23 November 2024, https://www.azom.com/news.aspx?newsID=33159.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.